Clinical, etiological and therapeutic aspects of cerebral folate deficiency

Expert Review of Neurotherapeutics

Volumn 15, Issue 7, 2015, Pages 793-802

  Molero Luis, Marta ^a   Serrano, Mercedes ^a   O'Callaghan, Maria M ^a   Sierra, Cristina ^a   Pérez Dueñas, Belén ^a   García Cazorla, Angels ^a   Artuch, Rafael ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

5 methyltetrahydrofolate; cerebral folate deficiency; choroid plexus; folate transport and metabolism; folic acid; folinic acid; neurological diseases

Indexed keywords

ANTICONVULSIVE AGENT; BETAINE; COBALAMIN; DIHYDROFOLATE REDUCTASE; FOLATE RECEPTOR 1; FOLATE TRANSPORTER; FOLIC ACID; FOLINIC ACID; HYDROXOCOBALAMIN; PYRIDOXINE; RIBOFLAVIN; SERINE;

ABSENCE OF SIDE EFFECTS; CENTRAL NERVOUS SYSTEM; CEREBRAL FOLATE DEFICIENCY; CHOROID PLEXUS; CLINICAL TRIAL (TOPIC); DIHYDROFOLATE REDUCTASE DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENE MUTATION; HUMAN; INBORN ERROR OF METABOLISM; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETT SYNDROME; REVIEW; SERINE DEFICIENCY; CEREBELLAR DISEASES; COMPLICATION; METABOLISM; VITAMIN DEFICIENCY;

CEREBELLAR DISEASES; FOLIC ACID; HUMANS; VITAMIN B DEFICIENCY;

EID: 84933499855     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1055322     Document Type: Review

References (62)

1. Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism, with special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 2011;34(1):75-81
2. Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J 2011;437(3):357-72
3. Visentin M, Diop-Bove N, Zhao R, Goldman ID. The intestinal absorption of folates. Annu Rev Physiol 2014;76:251-74
4. Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr 2011;21:177-201
5. Qiu A, Jansen M, Sakaris A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006;127(5):917-28
6. Hou Z, Matherly LH. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1. Curr Top Membr 2014;73:175-204
7. Zhao R, Goldman ID. Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors. Mol Aspects Med 2013;34(2-3):373-85
8. Spector R, Johanson C. Vectorial ligand transport through mammalian choroid plexus. Pharm Res 2010;27(10):2054-62
9. Steinfeld R, Grapp M, Kraetzner R, et al. Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 2009;85(3):354-63
10. Ramaekers VT, Blau N. Cerebral folate deficiency. Dev Med Child Neurol 2004;46(12):843-51
11. Serrano M, Pérez-Dueñas B, Montoya J, et al. Genetic causes of cerebral folate deficiency: clinical, biochemical and therapeutic aspects. Drug Discov Today 2012;17(23-24):1299-306
12. Perez-Dueñas B, Ormazábal A, Toma C, et al. Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects. Arch Neurol 2011;68(5):615-21
13. Mangold S, Blau N, Opladen T, et al. Cerebral folate deficiency: a neurometabolic syndrome? Mol Genet Metab 2011;104(3):369-72
14. Opladen T, Blau N, Ramaekers VT. Effect of antiepileptic drugs and reactive oxygen species on folate receptor 1 (FOLR1)-dependent 5-methyltetrahydrofolate transport. Mol Genet Metab 2010;101(1):48-54
15. Ramaekers VT, Rothenberg SP, Sequeira JM, et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 2005;352(19):1985-91
16. Watkins D, Rosenblatt DS. Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis 2012;35(4):665-70
17. nd edition. Blau N, Duran M, Blaskovics ME, Gibson KM, Eds. Springer-Verlag; Berlin, Germany: 2003. 243-60
18. Ormazabal A, Perez-Dueñas B, Sierra C, et al. Folate analysis for the differential diagnosis of profound cerebrospinal fluid folate deficiency. Clin Biochem 2011;44(8-9):719-21
19. rd edition. Milupa Metabolics GmbH & CoKG 61381; Frieddrichsdorf, Germany: 2011
20. D'Aco KE, Bearden D, Watkins D, et al. Severe 5,10-methylenetetrahydrofolate reductase deficiency and two MTHFR variants in an adolescent with progressive myoclonic epilepsy. Pediatr Neurol 2014;51(2):266-70
21. Prasad AN, Rupar CA, Prasad C. Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev 2011;33(9):758-69
22. Banka S, Blom HJ, Walter J, et al. Identification and characterization of an inborn error of metabolism caused by dihydrofolate reductase deficiency. Am J Hum Genet 2011;88(2):216-25
23. Cario H, Smith DE, Blom H, et al. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet 2011;88(2):226-31
24. van der Crabben SN, Verhoeven-Duif NM, Brilstra EH, et al. An update on serine deficiency disorders. J Inherit Metab Dis 2013;36(4):613-19
25. Kraoua I, Wiame E, Kraoua L, et al. 3-Phosphoglycerate dehydrogenase deficiency: description of two new cases in tunisia and review of the literature. Neuropediatrics 2013;44(5):281-5
26. Shin DS, Mahadeo K, Min SH, et al. Identification of novel mutations in the proton-coupled folate transporter (PCFT-SLC46A1) associated with hereditary folate malabsorption. Mol Genet Metab 2011;103(1):33-7
27. Perez-Duenas B, Toma C, Ormazábal A, et al. Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 2010;33(6):795-802
28. Garcia-Cazorla A, Quadros EV, Nascimento A, et al. Mitochondrial diseases associated with cerebral folate deficiency. Neurology 2008;70(16):1360-2
29. Serrano M, García-Silva MT, Martin-Hernandez E, et al. Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features. Mitochondrion 2010;10(5):429-32
30. Pineda M, Ormazabal A, López-Gallardo E, et al. Cerebral folate deficiency and leukoencephalopathy caused by mitochondrial DNA deletion. Ann Neurol 2006;59(2):394-8
31. Allen RJ, DiMauro S, Coulter DL, et al. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 1983;13(6):679-82
32. Hasselmann O, Blau N, Ramaekers VT, et al. Cerebral folate deficiency and CNS inflammatory markers in Alpers disease. Mol Genet Metab 2010;99(1):58-61
33. Ramaekers VT, Weis J, Sequeira JM, et al. Mitochondrial Complex I encephlomyopathy and cerebral 5-Methyltetrahydrofolate deficiency. Neuropediatrics 2007;38(4):184-7
34. Tanji K, Schon EA, DiMauro S, Bonilla E. Kearns-Sayre syndrome: oncocytic transformation of choroids plexus epithelium. J Neurol Sci 2000;178(1):29-36
35. Quijada-Fraile P, O Callaghan M, Martín-Hernández E, et al. Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and kearns-sayre syndrome orphanet. J Rare Dis 2014;9(1):3
36. Morris MS. Folate, homocysteine, and neurological function. Nutr Clin Care 2002;5(3):124-32
37. Ramaekers VT, Thöny B, Sequeira JM, et al. Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Mol Genet Metab 2014;113(4):307-14
38. Frye RE, Sequeira JM, Quadros EV, et al. Cerebral folate receptor autoantibodies in autism. spectrum disorder. Mol Psychiatry 2013;18(3):369-81
39. Moretti P, Peters SU, Del Gaudio D, et al. Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency. J Autism Dev Disord 2008;38(6):1170-7
40. Ramaekers VT, Blau N, Sequeira JM, et al. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics 2007;38(6):276-81
41. Moretti P, Sahoo T, Hyland K, et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 2005;64(6):1088-90
42. Ramaekers VT, Hansen SI, Holm J, et al. Reduced folate transport to the CNS in female Rett patients. Neurology 2003;61(4):506-15
43. Ormazabal A, Artuch R, Vilaseca MA, et al. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Neuropediatrics 2005;36(6):380-5
44. Hagebeuk EE, Koelman JH, Duran M, et al. Clinical and electroencephalographic effects of folinic acid treatment in Rett síndrome patients. J Child Neurol 2011;26(6):718-23
45. Hagebeuk EE, Duran M, Koelman JH, et al. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study. J Child Neurol 2012;27(3):304-9
46. Temudo T, Rios M, Prior C, et al. Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment. Brain Dev 2009;31(1):46-51
47. Glaze DG, Percy AK, Motil KJ, et al. A study of the treatment of Rett syndrome with folate and betaine. J Child Neurol 2009;24(5):551-6
48. Neul JL, Maricich SM, Islam M, et al. Spinal fluid 5-methyltetrahydrofolate levels are normal in Rett syndrome. Neurology 2005;64(12):2151-2
49. Morrell MJ. Folic Acid and Epilepsy. Epilepsy Curr 2002;2(2):31-4
50. Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992;42(4 Suppl 5):17-24
51. Opladen T, Blau N, Ramaekers VT. Effect of antiepileptic drugs and reactive oxygen species on folate receptor 1 (FOLR1)-dependent 5-methyltetrahydrofolate transport. Mol Genet Metab 2010;101(1):48-54
52. Choi JH, Yates Z, Veysey M, et al. Contemporary issues surrounding folic Acid fortification initiatives. Prev Nutr Food Sci 2014;19(4):247-60
53. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006;5(11):949-60
54. Hommes OR, Obbens EA. The epileptogenic action of Na-folate in the rat. J Neurol Sci 1972;16(3):271-81
55. Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 2014;44(5):480-8
56. Forssen KM, Jagerstad MI, Wigertz K, Witthoft CM. Folates and dairy products: a critical update. J Am Coll Nutr 2000;19(2 Suppl):100S-10S
57. Rajagopalan PT, Zhang Z, McCourt L, et al. Interaction of dihydrofolate reductase with methotrexate: ensemble and single molecule kinetics. Proc Natl Acad Sci USA 2002;99(21):13481-6
58. Zhao R, Matherly LH, Goldman ID. Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues. Expert Rev Mol Med 2009;11:e4
59. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006;84(1):156-61
60. Ormazabal A, García-Cazorla A, Pérez-Dueñas B, et al. Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population. Clin Chim Acta 2006;371(1-2):159-62
61. Verbeek M.M, Blom AM, Wevers RA, et al. Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations. Mol Genet Metab 2008;95(3):127-32
62. Aylett SB, Neergheen V, Hargreaves IP, et al. Levels of 5-methyltetrahydrofolate and ascorbic acid in cerebrospinal fluid are correlated: implications for the accelerated degradation of folate by reactive oxygen species. Neurochem Int 2013;63(8):750-5